Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23248254

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Feb 1
First author
Moskowitz AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Moskowitz AJ
      type
      Author
    2. name
      Hamlin PA Jr
      type
      Author
    3. name
      Perales MA
      type
      Author
    4. name
      Gerecitano J
      type
      Author
    5. name
      Horwitz SM
      type
      Author
    6. name
      Matasar MJ
      type
      Author
    7. name
      Noy A
      type
      Author
    8. name
      Palomba ML
      type
      Author
    9. name
      Portlock CS
      type
      Author
    10. name
      Straus DJ
      type
      Author
    11. name
      Graustein T
      type
      Author
    12. name
      Zelenetz AD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Moskowitz AJ
      type
      Author
    2. name
      Hamlin PA Jr
      type
      Author
    3. name
      Perales MA
      type
      Author
    4. name
      Gerecitano J
      type
      Author
    5. name
      Horwitz SM
      type
      Author
    6. name
      Matasar MJ
      type
      Author
    7. name
      Noy A
      type
      Author
    8. name
      Palomba ML
      type
      Author
    9. name
      Portlock CS
      type
      Author
    10. name
      Straus DJ
      type
      Author
    11. name
      Graustein T
      type
      Author
    12. name
      Zelenetz AD
      type
      Author
    bibliography ids
    1. nci-bib-ae83a64930bcd8f248b7a89d
    book metadata
    content sha256
    63e5996251b15151ef652c3d4cb8e1cad920844d9b533c0f51ac3264014181e8
    document type
    citation
    dois
    1. 10.1200/JCO.2012.45.3308
    electronic publication date
    display
    2012 Dec 17
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23248254
    immutable id
    pubmed:23248254@63e5996251b15151ef652c3d4cb8e1cad920844d9b533c0f51ac3264014181e8
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    4
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    456-60
    volume
    31
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23248254
      provenance
      batch id
      99e85dbb34a1a3011c9a
      provider
      NCBI PubMed ESummary
      record sha256
      58cd2638068fc6ca9cb7c77e7bd6a68486bf4e824ec240318ad2f750af18cb9f
      response sha256
      1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
      retrieved at
      2026-09-09T23:46:52.860383+00:00
      publication date
      display
      2013 Feb 1
      precision
      day
      year
      2013
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23248254/
      title
      Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma.

      Preserved source evidence · Not medical advice